Innovation of Novel Antibiotics: An Economic Perspective

Treatment of Multidrug-Resistant Gram-Negative Infections in Children

(2014) A. J. Hsu et al.   CLINICAL INFECTIOUS DISEASES

10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

(2013) H. W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09

(2013) Daniel J. Shapiro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Future of Antibiotics and Resistance

(2013) Brad Spellberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

The true cost of antimicrobial resistance

(2013) R. Smith et al.   BMJ-British Medical Journal

3Rs for innovating novel antibiotics: sharing resources, risks, and rewards

(2012) A. D. So et al.   BMJ-British Medical Journal

Existing classes of antibiotics are probably the best we will ever have

(2012) M. Cormican et al.   BMJ-British Medical Journal

Improving Antimicrobial Stewardship The Evolution of Programmatic Strategies and Barriers

(2011) Birgir Johannsson et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock

(2009) Anand Kumar et al.   CHEST